Advertisement
Advertisement
NKTR
Nektar Therapeutics
59.38
USDSponsored
+0.17
+0.29%
Jun 12, 16:00 UTC -4
Closed
After-Market
59.96
+0.58
+0.98%
Nektar Therapeutics Financial Snapshot
| Market Cap | 2.03B |
| Beta | 1.16 |
| Earnings Per Share (EPS) | -10.20 |
| Price-to-Book (P/B) Ratio | 17.66 |
| Operating Margin | -287.43% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -386.16% |
| Current Ratio | 4.97% |
| Free Cash Flow | -208.68M |
Trending Stocks
Advertisement